Learn More
Medchemexpress LLC Zingiberen newsaponin | 91653-50-8 | 99.7% | 1047.18 g/mol | C51H82O22 | 10 MG

Supplier: Medchemexpress LLC HYN228210MG
Zingiberen newsaponin is an orally active steroid saponin used in preclinical research with reported anticancer and neuroprotective activities. It is provided as a solid for laboratory studies and is intended for research use only.
- Orally active steroid saponin with reported in vitro and in vivo activity.
- Exerts anti-hepatocellular carcinoma effects by inhibiting autophagy and the AKR1C1/JAK2/STAT3 pathway.
- Activates oxidative stress and mitochondrial pathways, promoting cancer cell apoptosis.
- Alleviates cerebral ischemia-reperfusion injury and reduces pro-inflammatory cytokines.
- Enhances antioxidant enzyme activity and protects nerve cells.
- Solid form; white to off-white appearance; store sealed away from moisture and light.
- Analytical purity reported at 99.68%.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.